4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000014
Options or other derivatives
- Chief Executive Officer acquired 570,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Congleton Jon Chief Executive Officer | 2025-02-13 | Grant or award · Stock Option | +570,000 | 570,000 | D: show line 1 in the form |
Loading xslF345X05/wk-form4_1740441525.xml…